163326002 - Project: tender_20881 - ACAN - Molecular Multiplex Assay for Detection of Enteric Protists (Канада - Тендер #67448724) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Канада (другие тендеры и закупки Канада) Организатор тендера: www.merx.com Номер конкурса: 67448724 Дата публикации: 03-10-2025 Источник тендера: www.merx.com |
||
Advance Contract Award Notice for a Molecular Multiplex Assay System to detect enteric protists, with intent to award a 2-year contract to Seegene Canada Inc.
00004741166
Issuing OrganizationOntario Shared Services
Solicitation TypeACAN - Advance Contract Award Notice (Formal)
Solicitation Number163326002
TitleProject: tender_20881 - ACAN - Molecular Multiplex Assay for Detection of Enteric Protists
Source IDSCRIBE
Ontario
Purchase TypeNot Stated
2025/10/02 12:43:00 PM EDT
Closing Date2025/10/16 04:00:00 PM EDT
Julie Capotorto
julie.capotorto@oahpp.ca
Advance Contract Award Notice – Molecular Multiplex Assay for Detection of Enteric Protists
Public Health Ontario (PHO) believes that the following procurement qualifies as a sole source or single source procurement. The purpose of this Advanced Contract Award Notice (ACAN) is to
determine if there are other proponents capable of meeting the requirements of the procurement for the following supplies for PHO.
Vendor: Seegene Canada Inc.
Product: Molecular Multiplex Assay System
Purpose: Detection of Enteric Protozoa
The PHO Parasitology program routinely performs microscopy for incoming requests of enteric parasite testing referred to as Ova and Parasite examinations. This testing is performed in four test
sites, London, Ottawa, Peterborough and Toronto. The program is seeking implementation of a molecular methodology to identify the most common and/or medically important enteric protists in
Ontario, namely Dientamoeba fragilis, Cryptosporidium, Giardia duodenalis, Entamoeba histolytica and Cyclospora. PHO is therefore seeking supply of a Health Canada approved assay system capable
of the detection of Dientamoeba fragilis, Cryptosporidium, Giardia duodenalis, Entamoeba histolytica, and Cyclospora from fecal clinical specimens.
PHO believes that there is only one supplier capable of supplying the required goods in the Canadian Market. PHO intends to award a 2-year term contract to Seegene Canada Inc for the products
described in the ACAN attachment.
This request does not constitute a call for tenders.